BPS804 + Placebo

Phase 2Withdrawn

1 views this week 0 watching💤 Quiet

Interest: 27/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Chronic-kidney Disease Stage 5D on Stable Hemodialysis

Conditions

Chronic-kidney Disease Stage 5D on Stable Hemodialysis

Trial Timeline

Aug 1, 2013 → Apr 1, 2014

NCT ID

NCT01806610

About BPS804 + Placebo

BPS804 + Placebo is a phase 2 stage product being developed by Novartis for Chronic-kidney Disease Stage 5D on Stable Hemodialysis. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01806610. Target conditions include Chronic-kidney Disease Stage 5D on Stable Hemodialysis.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01806610	Phase 2	Withdrawn	Aug 1, 2013	Apr 1, 2014	Chronic-kidney Disease Stage 5D on Stable Hemodialysis